99 related articles for article (PubMed ID: 35656863)
1. Leukocyte cell-derived chemotaxin 2 correlates with pediatric non-alcoholic fatty liver disease.
Paine-Cabrera D; Harvey LK; Robarts DR; Pritchard MT; Thyfault J; Weinman SA; Apte U; Slowik V
Clin Transl Sci; 2023 Dec; 16(12):2719-2728. PubMed ID: 37877453
[TBL] [Abstract][Full Text] [Related]
2. Mimicking kidney flow shear efficiently induces aggregation of LECT2, a protein involved in renal amyloidosis.
Ha JH; Xu Y; Sekhon H; Zhao W; Wilkens S; Ren D; Loh SN
J Biol Chem; 2024 May; 300(5):107231. PubMed ID: 38537700
[TBL] [Abstract][Full Text] [Related]
3. Mimicking Kidney Flow Shear Efficiently Induces Aggregation of LECT2, a Protein Involved in Renal Amyloidosis.
Ha JH; Xu Y; Sekhon H; Wilkens S; Ren D; Loh SN
bioRxiv; 2023 Jul; ():. PubMed ID: 37503176
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of LECT2 and relevance to immune infiltration in hepatocellular carcinoma.
Qin J; Sun W; Zhang H; Wu Z; Shen J; Wang W; Wei Y; Liu Y; Gao Y; Xu H
Front Genet; 2022; 13():951077. PubMed ID: 36160006
[No Abstract] [Full Text] [Related]
5. Leukocyte cell-derived chemotaxin 2 regulates epithelial-mesenchymal transition and cancer stemness in hepatocellular carcinoma.
Chu TH; Ko CY; Tai PH; Chang YC; Huang CC; Wu TY; Chan HH; Wu PH; Weng CH; Lin YW; Kung ML; Fang CC; Wu JC; Wen ZH; Lee YK; Hu TH; Tai MH
J Biol Chem; 2022 Oct; 298(10):102442. PubMed ID: 36055405
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET.
Shirasaki T; Yamagoe S; Shimakami T; Murai K; Imamura R; Ishii KA; Takayama H; Matsumoto Y; Tajima-Shirasaki N; Nagata N; Shimizu R; Yamanaka S; Abe A; Omura H; Kawaguchi K; Okada H; Yamashita T; Yoshikawa T; Takimoto K; Taharaguchi M; Takatsuka S; Miyazaki Y; Tamai T; Tanabe Y; Kurachi M; Yamamoto Y; Kaneko S; Matsumoto K; Takamura T; Honda M
Nat Commun; 2022 Jun; 13(1):3176. PubMed ID: 35676290
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum levels of leukocyte cell-derived chemotaxin 2 are associated with the prevalence of metabolic syndrome.
Zheng X; Lu J; Xiang S; Zou P; Chen H; Liu J; Zeng C; He Y
Acta Diabetol; 2024 May; 61(5):643-655. PubMed ID: 38383671
[TBL] [Abstract][Full Text] [Related]
8. Interorgan communication with the liver: novel mechanisms and therapeutic targets.
Zhao J; Zhang X; Li Y; Yu J; Chen Z; Niu Y; Ran S; Wang S; Ye W; Luo Z; Li X; Hao Y; Zong J; Xia C; Xia J; Wu J
Front Immunol; 2023; 14():1314123. PubMed ID: 38155961
[TBL] [Abstract][Full Text] [Related]
9. Association between Leukocyte Cell-Derived Chemotaxin 2 and Metabolic and Renal Diseases in a Geriatric Population: A Pilot Study.
Kuzan A; Maksymowicz K; Królewicz E; Lindner-Pawłowicz K; Zatyka P; Wojnicz P; Nowaczyński M; Słomczyński A; Sobieszczańska M
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137613
[TBL] [Abstract][Full Text] [Related]
10. Liver infiltration of multiple immune cells during the process of acute liver injury and repair.
Xie Y; Zhong KB; Hu Y; Xi YL; Guan SX; Xu M; Lin Y; Liu FY; Zhou WJ; Gao Y
World J Gastroenterol; 2022 Dec; 28(46):6537-6550. PubMed ID: 36569272
[TBL] [Abstract][Full Text] [Related]
11. Expression of a neutrophil chemotactic protein LECT2 in human hepatocytes revealed by immunochemical studies using polyclonal and monoclonal antibodies to a recombinant LECT2.
Yamagoe S; Akasaka T; Uchida T; Hachiya T; Okabe T; Yamakawa Y; Arai T; Mizuno S; Suzuki K
Biochem Biophys Res Commun; 1997 Aug; 237(1):116-20. PubMed ID: 9266841
[TBL] [Abstract][Full Text] [Related]
12. The molecular structure and role of LECT2 or CHM-II in arthritis, cancer, and other diseases.
Zhu S; Bennett S; Li Y; Liu M; Xu J
J Cell Physiol; 2022 Jan; 237(1):480-488. PubMed ID: 34550600
[TBL] [Abstract][Full Text] [Related]
13. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver.
Ovejero C; Cavard C; Périanin A; Hakvoort T; Vermeulen J; Godard C; Fabre M; Chafey P; Suzuki K; Romagnolo B; Yamagoe S; Perret C
Hepatology; 2004 Jul; 40(1):167-76. PubMed ID: 15239100
[TBL] [Abstract][Full Text] [Related]
14. The emerging roles of leukocyte cell-derived chemotaxin-2 in immune diseases: From mechanisms to therapeutic potential.
Zhu MH; Liu YJ; Li CY; Tao F; Yang GJ; Chen J
Front Immunol; 2023; 14():1158083. PubMed ID: 36969200
[TBL] [Abstract][Full Text] [Related]
15. Role of leukocyte cell-derived chemotaxin 2 as a biomarker in hepatocellular carcinoma.
Okabe H; Delgado E; Lee JM; Yang J; Kinoshita H; Hayashi H; Tsung A; Behari J; Beppu T; Baba H; Monga SP
PLoS One; 2014; 9(6):e98817. PubMed ID: 24892551
[TBL] [Abstract][Full Text] [Related]
16. LECT2: A pleiotropic and promising hepatokine, from bench to bedside.
Xie Y; Fan KW; Guan SX; Hu Y; Gao Y; Zhou WJ
J Cell Mol Med; 2022 Jul; 26(13):3598-3607. PubMed ID: 35656863
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
